Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 25% ± 8% | |
vein endothelial cell | 5 studies | 25% ± 7% | |
endothelial cell of vascular tree | 3 studies | 16% ± 0% |
Insufficient scRNA-seq data for expression of MEOX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2854.46 | 458 / 459 | 64% | 6.99 | 719 / 1118 |
esophagus | 91% | 642.88 | 1309 / 1445 | 48% | 2.65 | 87 / 183 |
bladder | 95% | 811.90 | 20 / 21 | 38% | 2.17 | 194 / 504 |
uterus | 86% | 704.87 | 146 / 170 | 46% | 5.62 | 212 / 459 |
intestine | 86% | 486.01 | 830 / 966 | 42% | 2.31 | 222 / 527 |
prostate | 53% | 250.27 | 129 / 245 | 75% | 4.45 | 378 / 502 |
skin | 68% | 467.51 | 1229 / 1809 | 47% | 5.23 | 221 / 472 |
stomach | 50% | 234.90 | 179 / 359 | 54% | 2.96 | 154 / 286 |
adipose | 100% | 3281.27 | 1200 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1244.90 | 852 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 13.48 | 28 / 29 |
muscle | 89% | 485.06 | 711 / 803 | 0% | 0 | 0 / 0 |
pancreas | 9% | 25.20 | 30 / 328 | 79% | 8.60 | 140 / 178 |
ovary | 12% | 95.14 | 21 / 180 | 76% | 20.60 | 325 / 430 |
spleen | 86% | 1066.61 | 207 / 241 | 0% | 0 | 0 / 0 |
thymus | 43% | 186.69 | 284 / 653 | 42% | 2.51 | 256 / 605 |
tonsil | 0% | 0 | 0 / 0 | 84% | 8.15 | 38 / 45 |
blood vessel | 61% | 412.52 | 819 / 1335 | 0% | 0 | 0 / 0 |
lung | 13% | 58.70 | 78 / 578 | 35% | 2.61 | 405 / 1155 |
kidney | 1% | 3.65 | 1 / 89 | 11% | 0.47 | 99 / 901 |
adrenal gland | 2% | 5.31 | 5 / 258 | 10% | 0.86 | 23 / 230 |
liver | 0% | 0 | 0 / 226 | 12% | 0.58 | 47 / 406 |
eye | 0% | 0 | 0 / 0 | 4% | 0.15 | 3 / 80 |
peripheral blood | 2% | 5.30 | 16 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 1% | 0.52 | 7 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060218 | Biological process | hematopoietic stem cell differentiation |
GO_0061056 | Biological process | sclerotome development |
GO_0001757 | Biological process | somite specification |
GO_0061053 | Biological process | somite development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0071837 | Molecular function | HMG box domain binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | MEOX1 |
Protein name | Homeobox protein MOX-1 (Mesenchyme homeobox 1) |
Synonyms | MOX1 |
Description | FUNCTION: Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development. Required for maintenance of the sclerotome polarity and formation of the cranio-cervical joints . Binds specifically to the promoter of target genes and regulates their expression. Activates expression of NKX3-2 in the sclerotome. Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation. While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner. Required for hematopoietic stem cell (HSCs) induction via its role in somitogenesis: specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the somite named endotome. . |
Accessions | ENST00000393661.2 [P50221-3] ENST00000549132.2 [P50221-2] ENST00000318579.9 [P50221-1] P50221 |